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Patients with either diabetes or hypercholesterolemia develop atherosclerosis and impair
healing of bone. In the present work we illustrated their role in limb ischemia during bone
cells differentiation of Wistar rat fetuses. Pregnant Wistar rats (n ¼ 20 each) were arranged
in three groups: control, diabetic or hypercholesterolemic. Diabetes was induced at the fifth
day of gestation using streptozotocin, and hypercholesterolemia was carried by feeding
virgin rats a diet containing 3% cholesterol for 6 wks prior to the onset of conception. At 13,
15, 17, and 19 d prenatal, pregnant rats were sacrificed, dissected, and fetuses were
removed. Hind limbs were separated and subjected to histological and transmission
electron microscopic examination, ossification, total calcium content of fetuses, iso-
enzymes alkaline and acid phosphatase and lactic dehydrogenase electrophoresis and
DNA damage. Fetuses of diabetic or hypercholesterolemic mothers exhibited delayed
histo-cytological differentiation of chondrocytes, and decreased periosteal ossification.
Alkaline and acid phosphatase as well as lactic dehydrogenase isoenzymes showed altered
diffusion rate and intensities of their bands reflecting their activities in both diseases
comparing with the control. Assessments of bone calcium contents revealed marked
reduction. Genomic expression of the degree of laddering (total DNA fragmented) or single-
cell gel electrophoresis was found to be increased in cartilage and bone cells of fetuses of
diabetic or hypercholesterolemic mothers. The authors concluded that both diseases had a
selective, dramatic effect during fetus development in this model by retarding the histo-
and cytological differentiation during limb bone growth. Both diseases increased the
average cell death in skeletal elements and blood vessels as a consequence of altered
alkaline and acid phosphatases and lactic dehydrogenase isoenzymes in accordance with
DNA damage.
Copyright 2014, Mansoura University. Production and hosting by Elsevier B.V. This is an
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Table 1 e Description of the percentages of diets
constituents in control, diabetic and
hypercholesterolemic groups.
Ingredient (%) Control Diabetic Hypercholesterolemic
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Hypercholsterolemia represents the common pathogenetic
factor for bone disease [1,2]. Researchers are still figuring out
exactly how diabetes changes cholesterol levels and contrib-
utes to vascular complications such as atherosclerosis [3].
Diabetes [4] or hypercholesterolemia [5] was interrelated with
each other and increased the oxidative stress and cell damage.
Recently, we reported that maternal diabetic or hyper-
cholesterolemic mothers exhibited massive damage of both
blood vessels and myocardial fibers of their fetuses [6] as well
as induce apparent hepatocyte damage [7] which may co-
operate in bone defects.
A very few number of studies have reported that type 1
diabetes altered bone remodeling by reducing the formation
of new bone, leading to osteopenia in humans and animals
[8,9]. Type 1 diabetes was found to cause a significant delay in
fracture healing [10](Lu et al., 2003) through a reduction of
bone mineral density as assessed in the lumbar spine and
proximal femur [11] and a decrease of bone formation
compared with normal individuals [8].
Experimental studies on diabetic mice and rats revealed
that the disease was concerned with reduction of bone for-
mation, expression of osteocalcin, collagen types and decrease
in bone healing [10], as well as increasing apoptosis of bone-
lining cells [11]. Kayal et al. [12] observed a decrease of carti-
lage tissue and new bone area post 16 days of onset of diabetes
in CD-1 mice. Won et al. [13] examined the inter-vertebral disk
of OLETF (diabetic) rats at 6 and 12months of age and detected
increased incidence of apoptotic index of notochordal cells,
which led to early intervertebral disc degeneration.
Atherosclerosis, like osteoporosis, is closely associated
with each other [1]. The enhanced risk of bone fracture was
the end result of accumulated damage [14]. Osteoclast for-
mation and function were influenced by numerous inflam-
matory factors mediated in atherogenesis such as tumor
necrosis factor -a which activated osteoclasts formation [15].
In experimental rats, Funaba et al. [16] reported a reduction of
bone formation in 10-week-old hypercholesterolemic rats,
suggesting inhibiting factor(s) for bone growth.
From the literature, there are no reports illustrating the
direct effects on the differentiation of skeletal cells. The pre-
sent study aims to outline the exact role of diabetes or hy-
percholesterolemia in histogenesis and cytological structures
of bone elements, bone isoenzyme lactic dehydrogenase
electrophoresis, and pattern of DNA damage of hind limb of
Wistar rat during prenatal growth.
Choline bitartrate 1 1 1
Cholesterol e e 3
Cholic acid e e 2
Thiouracil e e 2
Cellulose 13 13 13
Casein 10 10 15
Soybean oil 5 5 15
Vitamins 2.5 2.5 2.5
Minerals 2.5 2.5 2.5
Moisture 7 7 7
Ash 4 4 3
Sucrose 10 10 5
Carbohydrates 10 10 5
Corn starch 15 15 52. Materials and methods
2.1. Induction of diabetes
Experimental diabetes mellitus was induced by a single
intraperitoneal injection of streptozotocin (60 mg/kg) in the
citrate buffer (pH 4.5) on the fifth day of gestation [17]. Control
animals received physiologic saline as a vehicle. Hyperglyce-
mia was verified by measuring the blood glucose at approxi-
mately 350 mg/dL.2.2. Induction of hypercholesterolemia
The experimental group was fed a hypercholesterolemic diet
according to Enkhmaa et al. [18]. The component of the diet
was illustrated in Table 1. The hypercholesterolemic diet was
composed of 3% cholesterol and 15% cocoa butter in accor-
dance with the standard diet formula. The rats were fed for
6 wks before the onset of gestation. The control group was
supplied a standard diet free from atherogenic components.2.3. Experimental animal work
This study and all procedures were approved by the Animal
Care and Bioethics of the Egyptian Committee, and the animal
work was done at Faculty of Science, Mansoura University.
Eighty fertile male and virgin female rats of Wistar strain
(Rattus norvegicus) (at a ratio of 1 male to 3 females) weighing
approximately 125 g body weight, were obtained fromHellwan
Breeding Farm, Ministry of Health, Egypt and used for experi-
mentation. They were housed in cages with good ventilation
on a 12-h light and dark cycle. Females were mated (1 male/3
females) overnight, and zero dates of gestation were deter-
mined the next morning by the presence of sperm in the
vaginal smear. The pregnant rats were arranged into three
groups (n ¼ 20 per each) as follows: C, control; D, diabetic; H,
hypercholesterolemic. Animalsweremaintained in free excess
of diet asmentioned in Table 1 andwater ad Libitum. At the end
of treatment, they were sacrificed by light diethyl ether anes-
thesia and dissected at 13, 15, 17, and 19 d prenatal. The tibia
regions from hind limbs were separated immediately from 13,
15, 17, and 19 d-old embryos and investigated as follows:2.4. Light microscopic investigations
Hind limb of fetuses of both control and experimentally-
treated fetuses were incised at 13-&15d-old and fixed in 10%
phosphate buffered formalin (pH 7.4), dehydrated in
ascending grades of ethyl alcohol, cleared in xylene and
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logical sections were cut and stained with hematoxylin and
eosin and examined under bright-field light microscopy.
2.5. Transmission electron microscopic investigations
Tibia specimens of 15d-old fetuses of both control and
experimental groups were separated and fixed immediately in
2% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for
12 hours. After washing, the specimens were postfixed in a
buffered solution of 1% osmium tetra oxide at 4 C for 1.5 h,
dehydrated in ascending grades of ethyl alcohol, and
embedded in epoxyeresin. Ultrathin sections were cut with a
diamond knife on an LKB Ultratome IV (LKB Instruments,
Bromma, Sweden) and mounted on grids, stained with uranyl
acetate and lead citrate, and examined under a Joel 100CX
transmission electron microscope (Musashino 3-chome
Akishima Tokyo 196- 8558, Japan).
2.6. Ossified length of femur, tibia and fibula
The ossification centers of hind limb of examined fetuses
were careful staining with the alizarin red “S” method. The
lengths of ossified femur, tibia and fibula were measured for
ten fetuses per each developmental stage in all groups.
2.7. Determination of calcium in fetuses
Calcium content was assayed in fresh fetuses (n ¼ 10) from
both the control and experimental groups at 15,17 and 19-days
prenatal. The fetuses were dissected and remove all the in-
ternal organs and dried in aven at 60 C for 6 hours. Lipid
extraction was carried out by using chloroform methyl
mixture 2:1. The fetuses' skeleton were weighed and digested
in 1mL of nitric acid at highest purity and dilutedwith 4mL bi-
distilled water and measure calcium by atomic absorption
spectrometry [19].
2.8. Lactate dehydrogenase and alkaline and acid
phosphatases isoenzymes electrophoresis
For determination of lactate dehydrogenase (LDH; 3.1.1.27),
tissues were homogenized and centrifuged at 3000  g for
5 min, 4 C. One mL protein dye (0.001% bromophenol blue)
plus 20mL 2% sucrosewere added and thirty mL of themixture
per gel slot was applied for each sample in enzyme electro-
phoresis. Polyacrylamide gel electrophoretic profiles of LDH
isoenzymes were utilized and software analysis of gel scans
done. Electrophoresis was essentially carried out according to
Lehnert and Berlet [20]. LDH enzyme bands were stained and
visualized in the presence of L-lactate as the substrate ac-
cording to the procedure of Shaw and Prasad [21]. Then, the
stained gels were fixed in 7% acetic acid (v/v) and documented
via scanning on HP Deskjet F370 All-in-One computer as-
sembly. Limb ALP is separated by electrophoresis through
alkaline buffered (pH 9.1) according to [22]. Electrophoresis
was performed at a constant current at 2.5 mA per gel column
at 18e20C. Incubation for alkaline phosphatase (E.C.3.1.3.1)
was carried out using Naphthol-AS-MX-phosphateas sub-
strate and fast red violet LB salt as the coupler. Incubations ofacid phosphatase (E.C.3.1.3.2) was undertaken at pH 5.0 using
alpha-naphthyl phosphate as substrate and hexazotized
pararosanilin as coupled agent, run in electrophoresis and
processed for visualization and photographed [23].
2.9. DNA fragmentation assay
DNA fragmentation was assayed by a modification of Duke
and Sellins [24]. Freshly isolated specimens were washed
twice with ice-cold phosphate-buffered saline and suspended
in 100 mL lysis buffer (10 mM Tris HCl/10 mM EDTA/0.5%
Triton X-100, pH 8.0), vortex-mixed, sonicated, and incubated
on ice for 20 min. After centrifugation at 4 C (14,000  g), the
supernatant containing fragmented (soluble) DNA was mixed
with lysis buffer (1 mL). Both samples were treated with
RNAse A (0.5mg/mL) for 1 h at 37 C and thenwith proteinase-
K (0.4 mg/mL; Sigma, St. Louis, MO, USA) for 1 h at 37 C. After
adding 20mL of 5MNaCl and 120mL isopropanol, the samples
were incubated overnight at 220 C, and the DNA concentra-
tions were determined and run on agarose gel electrophoresis
and visualized.
2.10. Single cell gel electrophoresis (Comet assay)
Specimens of both control and experimental diseased groups
were homogenized in chilled homogenizer buffer (pH 7.5)
containing 75mMNaCl and 24mMNa2EDTA (pH 13), to obtain
a 10% tissue solution. Six mL of the homogenate was sus-
pended on 0.5% lowmelting agarose and sandwiched between
a layer of 0.6% normal-melting agarose and a top layer of 0.5%
agarose on fully frosted slides. The slides were kept on ice
during the polymerization of each gel layer. After solidifica-
tion, the slides were immersed in a lysis solution (1% sodium
surcosinate, 2.5 m NaCl, 100 mM Na2EDTA, 10 mm TriseHCl,
1% Triton X-100, and 10% DMSO) at 4 C for 1 h, then placed in
electrophoresis buffer to allow DNA to unwind. Electropho-
resis was performed for 10 min at 300 mA and 1 V/cm. The
slides were neutralized with Tris HCL buffer, pH 7.5, and
stained with 20 mg/mL ethidium bromide. Each slide was
analysed using a Leitz Orthoplan (Wetzlar, Germany) epi-
fluorescencemicroscope. One hundred cells were analysed on
each slide using the Comet assay II automatic digital analysis
system [25].
2.10.1. Statistical analysis
Statistical analysis was carried out between the control and
each experimental group and for each developmental stage.
Means and standard deviations were calculated for each
result. Student's t test was applied and the differences were
considered statistically significant from the control at
P < 0.05.3. Results
3.1. Light and ultrastructural observations
At light microscopic level, control 13-d old embryos exhibited
the presence of ossification centers in the center of the
diaphysis of both femur and tibia. The extra parts of the
Fig. 1 e Photomicrographs of histologic sections of hind limb of 13 d-old embryos. Inset B in each image (1e3) represents a
magnification of A in the respective image. 1. Control, A. Tibia with primary ossification centers and phalanges with
hypertrophied chondrocytes. 2. Fetuses maternally diabetic, A. Shows chondrification of tibia and phalanges. 3. Fetuses
maternally hypercholesterolemic, A and C. Show chondrified tibia and phalanges. Abbreviations: F: foot; OC: ossification
centres; Pch: perichondrium; Ph: phalanges; POS: periosteal ossification; T: tibia.
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showed marked chondrification. The femur and tibial shafts
were ensheathed by perichondrium sheath, several cell layers
thick except the ossification centers, where sprouts of osteo-
blast progenitor cells become invade. The mid tarsal, meta-
tarsal and phalanges possessed the presence of hypertrophied
cartilage cells (Fig. 1 1A & B).Fig. 2 e Photomicrographs of histologic sections of hind limb o
tibia and phalanges. B. Periosteum and bone invasion. C. Incre
maternally diabetic, A. Tibia showing decreased mineralization
chondrification of phalanges. D. Delayed development of both pe
hypercholesterolemic, showing decreased ossification of tibia (A
bone marrow; BT: bone trabecula.In contrast, 13 d-old embryos of both diabetic or hyper-
cholesterolemic mothers exhibited delayed chondrification of
both femur, tibia and distal tarsal, metatarsal and phalanges
compared with the control. There is a marked comparatively
reduced periosteal ossification centers in both femur and tibia
(Fig. 2 2AeC).f 15 d-old embryos. 1. Control, A. Periosteal ossification of
ased cellularity of perichondrium of phalanges. 2. Fetuses
of calcified tibia. B. Periosteal bone invasion. C. Decreased
richondrial sheath and chondrocytes. 3. Fetusesmaternally
and C) and chondrified phalanges (B). Abbreviations: BM:
e g y p t i a n j o u r n a l o f b a s i c a nd a p p l i e d s c i e n c e s 2 ( 2 0 1 5 ) 1e1 2 5In control 15 d-old embryos, ossification proceeded in
different parts of hind limb regions, with characteristic
regular arrangement of cartilages zones within the limb
regions. The ossification centers proceeded with markedFig. 3 e Transmission electron micrographs of tibia of control 1
Osteoprogenitor cells in close proximity to degenerated chondr
calcium deposits at the peripheral surface of degenerated chon
degenerated chondrocytes. G and H. Normal blood vessel withi
Abbreviations: CB: chondroblasts; CC: chondrocyte; DC: degene
endothelial cells; F: fibroblast; N: nucleus; OsB: osteoblasts; POSprogress of dark-brown deposits of mineralized calcium
salts (Fig. 2, 1AeC). In contrast, 15 d-old embryos of either
diabetic or hypercholsterolemic mothers exhibited
comparatively reduction of ossification centers in5 d-old embryo. A. Periosteal sheath formation. B.
ocytes. C and D. Abundant distribution of mineralized
drocytes. E and F. Numerous osteoblast cells in between
n periosteal sheath having normal endothelial lining cells.
rated chondrocytes; DCC: degenerated cartilage cells; EC:
: periosteal ossification.
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phalanges was detected but not matched with the control
(Fig. 2, 2A-D and 2, 3AeC).
At the ultra-structural level, the control tibia of 15d-old
fetuses possessed electron-dense mineralization calcium
salts within the periosteum and in-between the hypertro-
phied chondrocytes. The periosteal sheath showed densely
grouping fibroblast cells and characteristic bundles of
collagen fibers. Nests of macrophages and osteoblast cells
representing osteoprogenitor cells were detected closely
adjacent to the calcified matrix of the breakdown chon-
drocytes. The osteoblast was characterized by the presence
of a well-developed rough endoplasmic reticulum with
dilated cisternae and large circular Golgi complex containing
multiple stacks (Fig. 3 AeH).
In contrast, embryos of either diabetic or hypercholester-
olemic mothers exhibited malformed perichondrial sheath
with peculiar presence of fibroblast cells lacking the cyto-
plasmic dendritic formation. The chondrocytes possessed
vacuolated cytoplasm and presence of collagen fibers.Many of
the chondrocytes attained considerable hypertrophy with the
massive breakdown of their cytoplasmic compartments and
nuclei with clumping of their nuclear chromatin (apoptosis)
(Figs. 4 AeF and 5 AeH).Fig. 4 e Transmission electron micrographs of tibia of 15 d-old
cells forming perichondrium. C. Chondrocytes with characteris
having cytoplasmwith vesicuolated rough endoplasmic reticulu
vessel with lining of the endothelium having abundant heteroc
RBCs: red blood cells; VRER: vesicuolated rough endoplasmic re3.2. Ossified length of femur, tibia and fibula
From Figs. 6 and 7, the ossified length of femur, tibia and fibula
of 15e19d-old fetuses of diabetic and hypercholesterolemic
mothers showed a marked decrease comparing with the
control.
3.3. Fetuses calcium content
From Fig. 8, fetuses of diabetic and hypercholesterolemic
mothers showed a marked reduction of calcium content.
3.4. Differential isoenzyme alkaline and acid
phosphatase and lactic dehydrogenase activity
Three bands of alkaline phosphatase isoenzymes are
expressed in control bone specimens of 15,17 and 19 d-old
fetuses. The rate of diffusion was markedly increased in
fetuses of diabetic and hypercholesterolemic mothers,
especially at 17 d-old. Isoenzyme fraction III appeared
missing in 19 d-old diabetic and hypercholesterolemic
fetuses. On the other hand, the intensity of acid
phosphatase isoenzymes was markedly reduced. Separation
of the isoenzyme and formation of the double band wasembryo maternally diabetic. A and B. Damaged fibroblast
tic nucleus and thin cytoplasm. D. Damaged chondroblast
m and electron-dense mitochondria. E and F. Swollen blood
hromatin. Abbreviations: Fi: fibroblast; M: mitochondria;
ticulum.
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olemic groups (Fig. 9).
The cartilage and bone elements lactic dehydrogenase
express five isoenzymes (LDH1-LDH5) (Fig. 10A). Both diabetes
or hypercholesterolemic groups exhibited either no expres-
sion of their isoenzyme bands or a decrease in its intensity in
15 d-old embryos. The expression of isoenzymes was mark-
edly detected in 17 and 19 d-old tibia of embryos of diseased
groups. However, double bands of isoenzyme IV were clearly
detected in hypercholesteromic-groups as well as increased
intensities of the expression of fraction V.Fig. 5 e Transmission electron micrographs of tibia of 15 d-old
Mineralized calcium deposits at periphery of osteocytes and sur
chondrocytes. The cytoplasm shows abundant mitochondria an
with cytoplasm rich in mitochondria and collagen fibres. G and
lining cells. Abbreviations: CF: collagen fibres; DEC: degenerated
mineralized calcium salts; N, nucleus; Os: osteoblast; V: vessel.3.5. Genomic DNA fragmentation
The genomic expression of the degree of laddering (total DNA
fragmented) increased in cartilage and bone cells of fetuses
maternally diabetic or hypercholesterolemic. The highest
incidence of genomic DNA fragmentation was markedly
increased in skeletal cells of diabetic mothers (Fig. 10B).
Also, following application of the Comet assay (single-cell
gel electrophoresis), the single-strand nucleotide/each skel-
etal cell of fetuses of both diabetic or hypercholesterolemic
mothers were streached with increased tail length and DNAembryo maternally hypercholesterolemic. A and B.
rounded by macrophages. C and D. Macrophage in between
d collagen bundles. E and F. Hypertrophied chondrocytes
H. Abnormal blood vessel within degenerated endothelial
endothelial cells; M: mitochondria; Ma: macrophage; MCS:
Fig. 6 e Lateral view photomacrograph of hind limb of
Alizarin red S preparation of 15, 17 and 19 d fetuses of
diabetic and hypercholesterolemic mothers. A, A1 &A2.
Control 15,17 & 19d-old.B, B1&B2. 15,17 &19d-old fetuses
maternally diabetic. C, C1 &C2. 15,17 &19d-old fetuses
maternally hypercholesterolemic. Note reduction of
ossified femur & tibio-fibula in experimental groups.
Fig. 7 e Ossified length of femur, tibia and fibula of Alizarin red
hypercholesterolemic mothers. Numer of fetuses/group (n ¼ 10
Fig. 8 e Calcium content of skeleton of 15, 17, and 19 d-old
fetuses maternally diabetic or hypercholesterolemic.
Numer of fetuses/group (n ¼ 10). *.Means significant at P
P < 0.05 student t test.
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manifesting apoptic cell death (Fig. 11).4. Discussion
Maintenance of skeletal integrity involves a dynamic biolog-
ical equilibrium between osteoclast-induced bone resorption
and osteoblast-mediated bone formation. Ossification of the
limb is carried throughout the endochondral period [26]. Ac-
cording to Polanco Ponce et al. [27], maternal diabetes in rats
was found to alter fetal development in a very similar manner
to that of humans.
The observed findings are the first to reveal that the
developing rat fetuses at 13 d-old prenatal of either diabetic or
hypercholesterolemic mothers showed a marked delay of
histogenesis of perichondrium and periosteal ossification of
hind limb. There was a qualitative decrease of both mineral-
ized calcium salts and cartilage-bone formation. Ultra-
structurally, both chondroblast and osteoblast cell's differen-
tiation were markedly delayed associated with deformedS preparation of 15, 17 and 19 d fetuses of diabetic and
). *.means significant at P P < 0.05 student t test.
Fig. 9 e Alkaline (A) and acid (B) isoenzyme electrophoresis
of tibia of 15, -17-, and 19 d-old fetuses maternally diabetic
or hypercholesterolemic shows increased intensity in
hypercholesterolemic fetuses and decreased flow rate and
activity intensities in diabetic fetuses.
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ing the primitive osteoid bone formation. The observed cyto-
logical findings were confirmed by a marked decrease of the
ossified length of limb bones as well as decreasedmineralized
calcium salts in the skeleton of 15, 17 and 19-d old fetuses of
diabetic or hypercholesterolemic mothers.
The present findings support the work of Eidem et al. [28]
and El-Sayyad et al. [29], who studied the effects of either
diabetes or hypercholesterolemia in pregnant mother and
their offspring. Our findings declare that decreased ossifica-
tion resulted from a reduction of calcium contents of embry-
onic bone tissues. Ossification defects may be attributed
either to disruption of either the Ca2 supply or the bone
maturation itself [30], or decreased placental transport ca-
pacity [31]. The ossification process in the fetus itself was
deficient, as indicated by decreased osteocalcin levels [32].
Retarded both bone growth [33,34] as well bone marrow
osteogenic progenitor cells [35] were the main consequences
of diabetes. Also, the mentioned authors mentioned that
diabetes cause a significantly decrease in levels of chondroitin
sulphate and heparan sulphate in the vertebrae of ovariecto-
mized diabetic rats. Both chondroitin sulphate and heparan
sulphate represent the main sources of cartilage and bone
formation [36]. Violation of the oxidant/antioxidant balance
by high glucose concentrations can cause massive cell dam-
age, increase in apoptotic events and defective embryonic
development [37,38]. Viccica et al. [39] reported thatcholesterol was synthesized by the liver and secreted as
circulating lipoproteins and plays a role in osteoblast differ-
entiation. Also, bone growth defects may be attributed to the
pathogenesis of non-alcoholic steatohepatits induced by hy-
percholesterolemia [7] as mentioned by Nakano et al. [40]. The
liver represents the main target of conversion of cholecalcif-
erol (vitamin D3) to 25-hydroxyvitamin D3 as well as 25-
hydroxyvitamin D2 [41] which regulating the concentration
of calcium and phosphate in the bloodstream and promoting
remodeling of bone [42]. Liver damage may disrupt bone dif-
ferention through reducing vitamin D synthesis.
From our findings, diabetes or hypercholesterolemia
exhibited missing expression of lactic dehydrogenase isoen-
zyme III in 15 d-old embryos. However, double bands of
isoenzyme IV were clearly detected in hypercholesteromic-
groups as well as increased intensities of the expression of
fraction V. These alterations of the isoenzymes reflect alter-
ations of their metabolic activities and may share in bone
cell's damage. Lactate dehydrogenase (LDH) has been used
extensively as a marker for cell death both in vitro and in vivo
[43]. It is more active in osteocytes [44]. Also dehydrogenases
except (glutamic dehydrogenase) were detected in osteocytes,
osteoblasts and osteoclasts in mandible of 5 day old rat. The
bone cells possess fully functional citric acid cycles, pentose
cycles, and the capacity to metabolize fatty acids and carbo-
hydrates [45]. Experimental diabetes was found to be associ-
ated with alterations of oxidative and glycolytic enzymes,
including lactic dehydrogenase [46].
Also, there was a marked alterations of bone alkaline and
acid phosphatase isoenzymes. The isoenzyme fraction III of
alkaline phosphase showed increased diffusion rates and
missing in 19 day-old fetuses. Acid phosphatase isoenzymes
showed marked reduction of their intensities and increase
diffusion rate. Bone-alkaline phosphatase is a useful param-
eter for monitoring changes in bone formation [47]. The dis-
tribution of acid and alkaline phosphatase activity were
identified in osteoclasts and adjacent osteocytes extracellu-
larly lining Howship's lacunae in endosteal resorbing surfaces
of rat tibia [48].
Also, feeding on diet high of cholesterol level revealed a
reduction of its utilization by fetal tissues, impairing growth
and consequently increasing the incidence of developmental
defects, including morphological and delayed ossification of
bones. The estimated ossified length of hind limb in fetuses of
hypercholesterolemic mothers showed apparent reduction.
The fetal growth defects may be associated with the damage
of myocardium and the development of atherosclerosis in
blood vessels, which reduces the transport of nutrients and
oxygen to tissues, as well as the cytotoxicity of hypercholes-
terolemia [6].
There a close association between both diabetes [49] or
hypercholesterolemia [50] and disruption of vitamin D syn-
thesis via decrease serum concentrations of 25-
hydroxycholecalciferol which intern impair bone cell
differentiation.
Also, there was a detected increase of DNA fragmentation
in bone tissues of fetuses of either hypercholesterolemic or
diabetic mothers. Chronic diabetes is one of the causes of
reactive oxygen species formation [51] where the cellular
response to reactive oxygen species led to the formation of
Fig. 10 e A. Lactic dehydrogenase isoenzyme electrophoresis pattern of tibia of 13-, 15-, 17-, and 19 d-old fetuses maternally
diabetic or hypercholesterolemic shows increased intensity in hypercholesterolemic fetuses and decreased intensities in
diabetic fetuses. B. Degree of laddering of DNA expressing DNA fragmentation in fetuses of either diabetic or
hypercholesterolemic mothers. Abbreviations: C: control; D: diabetic; H: hypercholesterolemic.
Fig. 11 e Comet assay of hind limb of 13, 15, 17, and 19 d-old fetuses. A, A1, A2, A3 are controls. B, B1, B2, B3 are fetuses
maternally diabetic. C, C1, C2, C3 are fetuses maternally hypercholesterolemic. Fetuses of either diabetic or
hypercholesterolemic mothers showed stretched bone cells with DNA damage (*).
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lipids, oxidative protein damage, alteration of cytoplasmic
and nuclear signal transduction, and DNA damage [52].
Takasu et al. [53] stated that DNA fragmentation suppos-
edly resulted from the accumulation of superoxide or hy-
droxyl radicals.
Also, our findings revealed that defects in blood vessel
formation during development of perichondrial and periosteal
sheath of the tibia of 15 d-old embryos of diabetic or hyper-
cholesterolemic mothers may reduce nutrient and oxygen
demands of skeletal elements, decreasing their differentiation
and mineralization.
As we know that the risk of peripheral vascular disease is
increased in diabetic and hypercholesterolemic patients.
Endothelial dysfunction, vascular smooth muscle cell
dysfunction, inflammation and hypercoagubility are the key
factors for peripheral vascular disease [6,54]. These compli-
cations may cause ischemia during bone differentiation and
consequently retarded cell growth and development.
Finally, we conclude that maternal diabetes and hyper-
cholesterolemia have a selective, dramatic effect during fetus
development, altering the histo- and cytological differentia-
tion and retarding bone growth. On the other hand, maternal
diabetes and hypercholesterolemia increased the rate of cell
death in skeletal elements and blood vessels as a result of
increased oxidative stress and altered lactic dehydrogenase
marker of cell damage in accordance with DNA damage.Competing interests
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